CRP and COVID-19: The study did show a possible protective impact associated with the use of ACEi/ARBs in COVID-19 based on the reduction in C-reactive protein (CRP) and D-dimer in these groups when compared to control groups, but the study suggested that larger sample numbers are required to confirm this effect [6].